Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,515,983 papers from all fields of science
Search
Sign In
Create Free Account
KCTD12 gene
Known as:
potassium channel tetramerization domain containing 12
, KIAA1778
, predominantly fetal expressed T1 domain
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
REN gene
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
KCTD12 is negatively regulated by Kit in gastrointestinal stromal tumors
Y. Suehara
,
K. Akaike
,
+15 authors
Tsuyoshi Saito
OncoTarget
2018
Corpus ID: 49331013
Our group has previously demonstrated that pfetin, encoded by the KCTD12 gene, is a strong prognostic biomarker for…
Expand
2016
2016
A Case of Pfetin Negative Gastrointestinal Stromal Tumor (GIST),Metastasized to the Liver Five Years after Surgery: A Surgical Challenge
Shunsuke Sakuraba
,
H. Orita
,
+5 authors
Koich Sato
2016
Corpus ID: 78855108
Background: Despite complete resection, GIST sometimes recurs and/or metastasizes. Accurate prognosis is needed and various risk…
Expand
2014
2014
Pfetin as a Risk Factor of Recurrence in Gastrointestinal Stromal Tumors
H. Orita
,
Tomoaki Ito
,
+6 authors
Koich Sato
BioMed Research International
2014
Corpus ID: 9003133
Background. Despite complete resection of gastrointestinal stromal tumors (GIST), recurrent and/or metastatic disease occurs…
Expand
2013
2013
Use of potassium channel tetramerization domain-containing 12 as a biomarker for diagnosis and prognosis of gastrointestinal stromal tumor.
T. Hasegawa
,
H. Asanuma
,
+5 authors
T. Kondo
Human Pathology
2013
Corpus ID: 6762476
Review
2013
Review
2013
Proteomic approach toward personalized sarcoma treatment: Lessons from prognostic biomarker discovery in gastrointestinal stromal tumor
T. Kondo
,
Y. Suehara
,
+5 authors
A. Kawai
PROTEOMICS - Clinical Applications
2013
Corpus ID: 23432873
Sarcomas range from curable tumors to those causing death via metastasis and recurrence. Thus, there is an urgent need for…
Expand
2013
2013
The prognostic value of pfetin: a validation study in gastrointestinal stromal tumors using a commercially available antibody.
Daisuke Kubota
,
Kenta Mukaihara
,
+11 authors
T. Yao
Japanese Journal of Clinical Oncology
2013
Corpus ID: 32531443
OBJECTIVE Adjuvant treatment with imatinib mesylate is an effective treatment for gastrointestinal stromal tumor. However, 50% of…
Expand
2013
2013
Abstract 25: Pfetin as a risk factor of recurrence in gastrointestinal stromal tumors.
H. Orita
,
Tomoaki Ito
,
+7 authors
Koich Sato
2013
Corpus ID: 76224536
Background: Despite complete resection, gastrointestinal stromal tumors (GIST) may recur or metastasize, depending on tumor grade…
Expand
2012
2012
[Proteomics for biomarker development toward personalized medicine].
T. Kondo
Rinsho byori. The Japanese journal of clinical…
2012
Corpus ID: 45592565
Cancer is a genetically and clinically diverse disease, and the therapeutic strategies should be optimized for individual cases…
Expand
2011
2011
Pfetin as a risk factor of recurrence in gastrointestinal stromal tumors (GIST).
H. Orita
Journal of Clinical Oncology
2011
Corpus ID: 26807177
e20519 Background: Despite complete resection, gastrointestinal stromal tumors (GIST) may recur or metastasize, depending on…
Expand
2008
2008
Young patients with multiple myeloma: favorable prognostic factors and better survival
Nature Clinical Practice Oncology
2008
Corpus ID: 41680078
yet been established. Suehara et al. conducted a quantitative expression study of intact proteins in GIST samples to investigate…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE